Related Experiment Video
Updated: Feb 18, 2026

Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice
Published on: July 11, 2025
Increased serum midkine levels in autism spectrum disorder patients
Erman Esnafoglu1, Selma Cirrik2
1a Department of Child and Adolescent Psychiatry, Faculty of Medicine, Research and Training Hospital , Ordu University , Ordu , Turkey.
Background:
Midkine (MK) is a heparin binding growth factor and is involved in neurogenesis, neural development and neuroprotection. Additionally, MK may contribute to cancer development and pathogenesis of neurodegenerative disorders and schizophrenia. Considering these effects of MK, this study researched whether MK is involved in autism spectrum disorders (ASD) pathogenesis.
Methods:
We evaluated serum MK levels of 38 patients with ASD and 32 healthy control group. MK levels were measured with ELISA, while ASD severity was assessed with Childhood Autism Rating Scale.
Results:
Our data showed that the serum MK concentration in ASD patients (mean ± SD, 11.51 ± 8.53 pg/ml) is significantly higher than healthy controls (mean ± SD, 6.19 ± 3.94 pg/ml) (p = 0.007).
Conclusions:
According to these results, MK may play a role in ASD pathogenesis.
Insights
Serum midkine (MK) levels are significantly higher in children with autism spectrum disorder (ASD). This suggests MK may play a role in the development of ASD.
Area of Science:
- Neuroscience
- Developmental Biology
- Biochemistry
Background:
- Midkine (MK) is a growth factor implicated in neural development and neuroprotection.
- MK is also associated with cancer, neurodegenerative disorders, and schizophrenia.
- Its potential role in autism spectrum disorders (ASD) remains unexplored.
Purpose of the Study:
- To investigate the involvement of midkine (MK) in the pathogenesis of autism spectrum disorders (ASD).
Main Methods:
- Serum MK levels were quantified using ELISA in 38 patients diagnosed with ASD.
- A control group of 32 healthy individuals was included for comparison.
- ASD severity was evaluated using the Childhood Autism Rating Scale.
Main Results:
- Serum MK concentrations were significantly elevated in ASD patients (11.51 ± 8.53 pg/ml) compared to healthy controls (6.19 ± 3.94 pg/ml).
- The difference in MK levels between the groups was statistically significant (p = 0.007).
Conclusions:
- Elevated serum MK levels suggest a potential role for midkine in the pathogenesis of autism spectrum disorders.
- Further research is warranted to elucidate the specific mechanisms by which MK influences ASD development.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...

